Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Respiratory Care
|
May 1, 2014
A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs
William A Prescott
American Journal of Pharmaceutical Education
|
July 16, 2023
Reviewing Promotion Dossiers as a Professional Responsibility
William A Prescott
American Journal of Pharmaceutical Education
|
November 4, 2022
The Five Most Important Lessons I Learned Along the Path to Clinical Professor
William A Prescott
American Journal of Pharmaceutical Education
|
July 24, 2021
Ascending the Levels of Leadership in Pharmacy Academia
William A Prescott
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
July 7, 2012
National survey of extended-interval aminoglycoside dosing in pediatric cystic fibrosis pulmonary exacerbations
William A Prescott
The Annals of Pharmacotherapy
|
August 19, 2004
Sincalide in patients with parenteral nutrition-associated gallbladder disease
William A Prescott, Imad F Btaiche
Pharmacotherapy
|
December 29, 2006
Clinical importance of carbapenem hypersensitivity in patients with self-reported and documented penicillin allergy
William A Prescott, Kristen A Kusmierski
Pharmacotherapy
|
June 28, 2005
Antiinflammatory therapies for cystic fibrosis: past, present, and future
William A Prescott, Cary E Johnson
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
April 6, 2012
Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression?
William A Prescott, David J Hutchinson
Pharmacotherapy
|
December 25, 2009
Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis
William A Prescott, Jerod L Nagel
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Respiratory Care
|
May 1, 2014
A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs
William A Prescott
American Journal of Pharmaceutical Education
|
July 16, 2023
Reviewing Promotion Dossiers as a Professional Responsibility
William A Prescott
American Journal of Pharmaceutical Education
|
November 4, 2022
The Five Most Important Lessons I Learned Along the Path to Clinical Professor
William A Prescott
American Journal of Pharmaceutical Education
|
July 24, 2021
Ascending the Levels of Leadership in Pharmacy Academia
William A Prescott
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
July 7, 2012
National survey of extended-interval aminoglycoside dosing in pediatric cystic fibrosis pulmonary exacerbations
William A Prescott
The Annals of Pharmacotherapy
|
August 19, 2004
Sincalide in patients with parenteral nutrition-associated gallbladder disease
William A Prescott, Imad F Btaiche
Pharmacotherapy
|
December 29, 2006
Clinical importance of carbapenem hypersensitivity in patients with self-reported and documented penicillin allergy
William A Prescott, Kristen A Kusmierski
Pharmacotherapy
|
June 28, 2005
Antiinflammatory therapies for cystic fibrosis: past, present, and future
William A Prescott, Cary E Johnson
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
April 6, 2012
Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression?
William A Prescott, David J Hutchinson
Pharmacotherapy
|
December 25, 2009
Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis
William A Prescott, Jerod L Nagel
Page
of 4